
Results
45
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
45 companies
Delivra Health Brands
Market Cap: CA$3.4m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.10
7D
-13.0%
1Y
-51.2%
1933 Industries
Market Cap: CA$2.6m
Engages in the cultivation, extraction, and production of cannabis products in the United States.
TGIF
CA$0.01
7D
0%
1Y
100.0%
CanadaBis Capital
Market Cap: CA$2.1m
Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.
CANB
CA$0.015
7D
0%
1Y
-66.7%
Ayurcann Holdings
Market Cap: CA$1.9m
Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.
AYUR
CA$0.01
7D
0%
1Y
-60.0%
RAMM Pharma
Market Cap: CA$1.8m
Operates in the pharmaceutical and medical product business in Uruguay and Poland.
RAMM
CA$0.015
7D
0%
1Y
50.0%
SOL Global Investments
Market Cap: CA$1.1m
A private equity firm specializing in emerging growth.
SOL
CA$0.04
7D
0%
1Y
-95.0%
Captor Capital
Market Cap: CA$767.1k
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.22
7D
0%
1Y
-48.8%
Vaxil Bio
Market Cap: CA$717.1k
A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.
VXL
CA$0.18
7D
-21.7%
1Y
-26.5%
Cytophage Technologies
Market Cap: CA$338.4k
A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.
CYTO.H
CA$0.005
7D
0%
1Y
-97.6%